UBSG 5.617 09/13/30 '29 MTN
Senior PreferredUSH42097EX11
IssuerUBS Group
Issuer LEI549300SZJ9VS8SGXAN81
SenioritySenior Preferred
Classification basisFIRDS debt seniority field
Total issued nominalUSD 1,750m
CurrencyUSD
Coupon5.617%
Interest typeFloating rate
Maturity date2030-09-13 · 4.1y
First trade date2024-05-09
Nominal per unitUSD 200,000
CFIDBVUFR
Reference venue (MIC)BTFE
Trading venues8
StatusActive
First seen2026-07-19
Last seen2026-08-04
Similar instruments
All Senior Preferred instrumentsActive floating rate Senior Preferred instruments in USD maturing within two years of this one, across the entity universe.
| ISIN | Issuer | Instrument | Coupon | Maturity | Amount |
|---|---|---|---|---|---|
| XS2638204367 | Barclays Bank Ireland | BARCLAYS BANK IRELAND PUBLIC LIMITED COMPANY USD 3,235,000 Worst-of Quanto Autocallable Equity Linked Securities linked to a Basket of Shares due 12 September 2030 | 0% | 2030-09-12 | USD 3m |
| US251526CX52 | Deutsche Bank | DBKG 4.999 09/11/30 '29 FRN | 4.999% | 2030-09-11 | USD 1,250m |
| XS2638204284 | Barclays Bank Ireland | BARCLAYS BANK IRELAND PUBLIC LIMITED COMPANY USD 1,250,000 Worst-of Quanto Autocallable Equity Linked Securities linked to a Basket of Equity Indices due 4 September 2030 | 0% | 2030-09-04 | USD 1m |
| US830505BL61 | SEB | SEB 9/30 (144a,FRN) SKANDINAVISKA ENSKILDA BANKEN AB | Not disclosed | 2030-09-03 | USD 300m |
| USW8454EBE78 | SEB | SEB 09/03/30 FRN | Not disclosed | 2030-09-03 | USD 300m |
| XS3184390444 | Goldman Sachs Bank Europe | GoldmSachsBkEur 25 09 2030 USD CMT | Not disclosed | 2030-09-25 | USD 10m |
XS2638204367Barclays Bank Ireland
US251526CX52Deutsche Bank
XS2638204284Barclays Bank Ireland
US830505BL61SEB
USW8454EBE78SEB
XS3184390444Goldman Sachs Bank Europe
Other instruments from UBS Group
Full profile| ISIN | Instrument | Seniority | Coupon | Maturity | Amount |
|---|---|---|---|---|---|
| US902613BL18 | UBSG 5.617 09/13/30 '29 MTN | SP | 5.617% | 2030-09-13 | USD 1,750m |
| US902613AA61 | UBSG 3.126 08/13/30 '29 FRN | SP | 3.126% | 2030-08-13 | USD 1,500m |
| USH42097AZ05 | UBSG 3.126 08/13/30 '29 FRN | SP | 3.126% | 2030-08-13 | USD 1,500m |
| CH1194000357 | UBSG 3.125 06/15/30 '29 MTN | SP | 3.125% | 2030-06-15 | EUR 1,000m |
| CH1348614152 | UBSG 2.113 05/22/30 '29 FRN | SP | 2.112% | 2030-05-22 | CHF 335m |
| CH1236363391 | UBSG 4.375 01/11/31 '30 MTN | SP | 4.375% | 2031-01-11 | EUR 1,000m |
| CH1512676888 | UBS Group AG EO-FLR Med.-T. Nts 2026(30/31) | SP | 3.125% | 2031-02-13 | EUR 1,500m |
| US225401BR89 | UBS 4.214 4/30 c29 (144a) UBS GROUP | SP | 4.214% | 2030-04-10 | USD 2,000m |
US902613BL18UBSG 5.617 09/13/30 '29 MTN
US902613AA61UBSG 3.126 08/13/30 '29 FRN
USH42097AZ05UBSG 3.126 08/13/30 '29 FRN
CH1194000357UBSG 3.125 06/15/30 '29 MTN
CH1348614152UBSG 2.113 05/22/30 '29 FRN
CH1236363391UBSG 4.375 01/11/31 '30 MTN
CH1512676888UBS Group AG EO-FLR Med.-T. Nts 2026(30/31)
US225401BR89UBS 4.214 4/30 c29 (144a) UBS GROUP